Senescent T cells: a potential biomarker and target for cancer therapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Zhao, 2020, Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment, Cellular & molecular immunology, 17, 27, 10.1038/s41423-019-0344-8
Barbarin, 2017, Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases, Frontiers in immunology, 8, 316, 10.3389/fimmu.2017.00316
Covre, 2020, The role of senescent T cells in immunopathology, Aging cell, 19, e13272, 10.1111/acel.13272
Liu, 2020, Senescent Tumor CD8(+) T Cells: Mechanisms of Induction and Challenges to Immunotherapy, Cancers, 12, 10.3390/cancers12102828
Akbar, 2016, Senescence of T Lymphocytes: Implications for Enhancing Human Immunity, Trends in immunology, 37, 866, 10.1016/j.it.2016.09.002
Effros, 1998, Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly, American journal of human genetics, 62, 1003, 10.1086/301845
Provinciali, 2009, Immunosenescence and cancer vaccines, Cancer immunology, immunotherapy : CII, 58, 1959, 10.1007/s00262-009-0665-z
Pereira, 2020, Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly, Frontiers in immunology, 11, 10.3389/fimmu.2020.583019
Barbe-Tuana, 2020, The interplay between immunosenescence and age-related diseases, Seminars in immunopathology, 42, 545, 10.1007/s00281-020-00806-z
Liu, 2020, Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy, The Journal of clinical investigation, 130, 1073, 10.1172/JCI133679
Ye, 2012, Human regulatory T cells induce T-lymphocyte senescence, Blood, 120, 2021, 10.1182/blood-2012-03-416040
Ye, 2013, Tumor-derived gammadelta regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence, Journal of immunology (Baltimore, Md : 1950), 190, 2403, 10.4049/jimmunol.1202369
Liu, 2018, Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition, Nature communications, 9, 249, 10.1038/s41467-017-02689-5
Ye, 2014, TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence, EMBO molecular medicine, 6, 1294, 10.15252/emmm.201403918
Henson, 2015, Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8(+) T-cell proliferation by distinct pathways, European journal of immunology, 45, 1441, 10.1002/eji.201445312
Mondal, 2013, p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes, The Journal of clinical investigation, 123, 5247, 10.1172/JCI70355
Henson, 2014, p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8(+) T cells, The Journal of clinical investigation, 124, 4004, 10.1172/JCI75051
Callender, 2018, Human CD8(+) EMRA T cells display a senescence-associated secretory phenotype regulated by p38 MAPK, Aging cell, 17, 10.1111/acel.12675
Song, 2018, T-cell Immunoglobulin and ITIM Domain Contributes to CD8(+) T-cell Immunosenescence, Aging cell, 17, 10.1111/acel.12716
Callender, 2020, Mitochondrial mass governs the extent of human T cell senescence, Aging cell, 19, e13067, 10.1111/acel.13067
Desdin-Mico, 2020, T cells with dysfunctional mitochondria induce multimorbidity and premature senescence, Science (New York, NY), 368, 1371, 10.1126/science.aax0860
Huang, 2020, CD8(+)CD57(+) T cells exhibit distinct features in human non-small cell lung cancer, Journal for immunotherapy of cancer, 8, 10.1136/jitc-2020-000639
Kunert, 2019, CD45RA(+)CCR7(-) CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab, Journal for immunotherapy of cancer, 7, 149, 10.1186/s40425-019-0608-y
Xu, 2017, Markers of T Cell Senescence in Humans, International journal of molecular sciences, 18, 10.3390/ijms18081742
Gustafson, 2017, Immune Checkpoint Function of CD85j in CD8 T Cell Differentiation and Aging, Frontiers in immunology, 8, 692, 10.3389/fimmu.2017.00692
Pereira, 2020, Sestrins induce natural killer function in senescent-like CD8(+) T cells, Nature immunology, 21, 684, 10.1038/s41590-020-0643-3
Suen, 2016, Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade, Leukemia, 30, 1716, 10.1038/leu.2016.84
Lanna, 2014, The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells, Nature immunology, 15, 965, 10.1038/ni.2981
Lanna, 2013, IFN-alpha inhibits telomerase in human CD8(+) T cells by both hTERT downregulation and induction of p38 MAPK signaling, Journal of immunology (Baltimore, Md : 1950), 191, 3744, 10.4049/jimmunol.1301409
Britanova, 2014, Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling, Journal of immunology (Baltimore, Md : 1950), 192, 2689, 10.4049/jimmunol.1302064
Bjorkstrom, 2012, CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells, Blood, 120, 3455, 10.1182/blood-2012-03-416867
Herranz, 2018, Mechanisms and functions of cellular senescence, The Journal of clinical investigation, 128, 1238, 10.1172/JCI95148
Parish, 2009, Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3, Journal of immunology (Baltimore, Md : 1950), 182, 4237, 10.4049/jimmunol.0803449
Nakamura, 2018, Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment, Cancer cell, 33, 634, 10.1016/j.ccell.2018.02.007
Castro, 2018, Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion, Frontiers in immunology, 9, 847, 10.3389/fimmu.2018.00847
Chen, 2018, CD8+CD28- T cells: not only age-related cells but a subset of regulatory T cells, Cellular & molecular immunology, 15, 734, 10.1038/cmi.2017.153
Montes, 2008, Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion, Cancer research, 68, 870, 10.1158/0008-5472.CAN-07-2282
Ramello, 2014, Tumor-induced senescent T cells promote the secretion of pro-inflammatory cytokines and angiogenic factors by human monocytes/macrophages through a mechanism that involves Tim-3 and CD40L, Cell death & disease, 5, e1507, 10.1038/cddis.2014.451
Di Mitri, 2011, Reversible senescence in human CD4+CD45RA+CD27- memory T cells, Journal of immunology (Baltimore, Md : 1950), 187, 2093, 10.4049/jimmunol.1100978
Lanna, 2017, A sestrin-dependent Erk-Jnk-p38 MAPK activation complex inhibits immunity during aging, Nature immunology, 18, 354, 10.1038/ni.3665
Trintinaglia, 2018, Features of Immunosenescence in Women Newly Diagnosed With Breast Cancer, Frontiers in immunology, 9, 1651, 10.3389/fimmu.2018.01651
Onyema, 2015, Chemotherapy-induced changes and immunosenescence of CD8+ T-cells in patients with breast cancer, Anticancer research, 35, 1481
Tsukishiro, 2003, Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer, Cancer immunology, immunotherapy : CII, 52, 599, 10.1007/s00262-003-0395-6
Akagi, 2008, Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer, International journal of clinical oncology, 13, 528, 10.1007/s10147-008-0789-8
Fornara, 2015, Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery, Oncoimmunology, 4, 10.1080/2162402X.2015.1036211
Tan, 2017, Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu., 29, 463, 10.21147/j.issn.1000-9604.2017.05.11
Knaus, 2018, Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy, JCI insight, 3, 10.1172/jci.insight.120974
Nunes, 2012, Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression, Clinical cancer research : an official journal of the American Association for Cancer Research, 18, 678, 10.1158/1078-0432.CCR-11-2630
Gothert, 2013, Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype, Cancer immunology, immunotherapy : CII, 62, 1697, 10.1007/s00262-013-1473-z
Liu, 2019, Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy, Journal of translational medicine, 17, 344, 10.1186/s12967-019-2097-7
Zelle-Rieser, 2016, T cells in multiple myeloma display features of exhaustion and senescence at the tumor site, Journal of hematology & oncology, 9, 116, 10.1186/s13045-016-0345-3
Magnano, 2017, T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcome, Leukemia & lymphoma, 58, 842, 10.1080/10428194.2016.1217525
Onyema, 2015, Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study, BMC cancer, 15, 1016, 10.1186/s12885-015-2013-3
Characiejus, 2002, Predictive value of CD8highCD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinoma, Anticancer research, 22, 3679
Tang, 2020, Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia, Clinical cancer research : an official journal of the American Association for Cancer Research, 26, 1763, 10.1158/1078-0432.CCR-19-3003
Bottomley, 2016, CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients, Journal of the American Society of Nephrology : JASN, 27, 1505, 10.1681/ASN.2015030250
Liu, 2019, Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer, Journal of translational medicine, 17, 120, 10.1186/s12967-019-1872-9
Song, 2013, Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy, Cancer immunology, immunotherapy : CII, 62, 1123, 10.1007/s00262-013-1424-8
Saavedra, 2016, Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients, Cancer immunology, immunotherapy : CII, 65, 37, 10.1007/s00262-015-1773-6
Bruni, 2019, Chemotherapy accelerates immune-senescence and functional impairments of Vdelta2(pos) T cells in elderly patients affected by liver metastatic colorectal cancer, Journal for immunotherapy of cancer, 7, 347, 10.1186/s40425-019-0825-4
Sanoff, 2014, Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer, Journal of the National Cancer Institute, 106, 057, 10.1093/jnci/dju057
Arina, 2019, Tumor-reprogrammed resident T cells resist radiation to control tumors, Nature communications, 10, 3959, 10.1038/s41467-019-11906-2
Li, 2015, Ionizing Radiation Impairs T Cell Activation by Affecting Metabolic Reprogramming, International journal of biological sciences, 11, 726, 10.7150/ijbs.12009
Zuazo, 2019, Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy, EMBO molecular medicine, 11, e10293, 10.15252/emmm.201910293
Hui, 2017, T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition, Science (New York, NY), 355, 1428, 10.1126/science.aaf1292
Kamphorst, 2017, Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent, Science (New York, NY), 355, 1423, 10.1126/science.aaf0683
Ferrara, 2021, Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy, Clinical cancer research : an official journal of the American Association for Cancer Research, 27, 492, 10.1158/1078-0432.CCR-20-1420
Moreira, 2019, Senescence markers: Predictive for response to checkpoint inhibitors, International journal of cancer, 144, 1147, 10.1002/ijc.31763
Wistuba-Hamprecht, 2017, Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients, European journal of cancer (Oxford, England : 1990), 73, 61, 10.1016/j.ejca.2016.12.011
Fehlings, 2019, Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment, Journal for immunotherapy of cancer, 7, 249, 10.1186/s40425-019-0695-9
Kasakovski, 2018, T cell senescence and CAR-T cell exhaustion in hematological malignancies, Journal of hematology & oncology, 11, 91, 10.1186/s13045-018-0629-x
Scherer, 2019, Chimeric Antigen Receptors for T-Cell Malignancies, Frontiers in oncology, 9, 126, 10.3389/fonc.2019.00126
Brudno, 2018, T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36, 2267, 10.1200/JCO.2018.77.8084
Zhu, 2015, Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57, Oncotarget, 6, 171, 10.18632/oncotarget.2767
Zhang, 2020, Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies, Molecular cancer, 19, 162, 10.1186/s12943-020-01282-7
Powell, 2005, Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy, Blood, 105, 241, 10.1182/blood-2004-06-2482
Krishna, 2020, Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer, Science (New York, NY), 370, 1328, 10.1126/science.abb9847
Wudhikarn, 2020, Dissecting factors influencing response to CAR T cell therapy in B lymphoid hematologic malignancies: from basic to practice, Leukemia & lymphoma, 61, 2324, 10.1080/10428194.2020.1761967
Beider, 2019, Upregulation of Senescent/Exhausted Phenotype of CAR T Cells and Induction of Both Treg and Myeloid Suppressive Cells Correlate with Reduced Response to CAR T Cell Therapy in Relapsed/Refractory B Cell Malignancies, Blood, 134, 3234, 10.1182/blood-2019-128068
Worel, 2019, Influence of CD27(-) CD28(-) T-Cells on the Therapeutic Outcome in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma after CART-Infusion, Blood, 134
Kowolik, 2006, CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells, Cancer research, 66, 10995, 10.1158/0008-5472.CAN-06-0160
Song, 2012, CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo, Blood, 119, 696, 10.1182/blood-2011-03-344275
Alizadeh, 2019, IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype, Cancer immunology research, 7, 759, 10.1158/2326-6066.CIR-18-0466
Stach, 2020, Inducible secretion of IL-21 augments anti-tumor activity of piggyBac-manufactured chimeric antigen receptor T cells, Cytotherapy, 22, 744, 10.1016/j.jcyt.2020.08.005
Jackaman, 2019, CD8(+) cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy, Oncoimmunology, 8, 10.1080/2162402X.2018.1564452
Vukmanovic-Stejic, 2018, Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase-induced inflammation, The Journal of allergy and clinical immunology, 142, 844, 10.1016/j.jaci.2017.10.032
Zhang, 2011, Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapy, Clinical cancer research : an official journal of the American Association for Cancer Research, 17, 4975, 10.1158/1078-0432.CCR-10-3328
Weng, 2016, IL-15 enhances the antitumor effect of human antigen-specific CD8(+) T cells by cellular senescence delay, Oncoimmunology, 5, 10.1080/2162402X.2016.1237327
Xu, 2013, Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor alphaSu/Fc fusion complex in syngeneic murine models of multiple myeloma, Cancer research, 73, 3075, 10.1158/0008-5472.CAN-12-2357
Wrangle, 2018, ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial, The Lancet Oncology, 19, 694, 10.1016/S1470-2045(18)30148-7
Drusbosky, 2020, Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study, Journal for immunotherapy of cancer, 8, 10.1136/jitc-2020-001098
Romee, 2018, First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation, Blood, 131, 2515, 10.1182/blood-2017-12-823757
Kagoya, 2018, A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects, Nature medicine, 24, 352, 10.1038/nm.4478
Gurusamy, 2020, Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies, Cancer cell, 37, 818, 10.1016/j.ccell.2020.05.004
Yoshida, 2020, The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice, Nature communications, 11, 2482, 10.1038/s41467-020-16347-w
Bharath, 2020, Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation, Cell metabolism, 32, 44, 10.1016/j.cmet.2020.04.015
Hachmo, 2020, Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial, Aging, 12, 22445
Werner, 2009, Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall, Circulation, 120, 2438, 10.1161/CIRCULATIONAHA.109.861005